L-R: Anna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford

18 June 2024FeaturesEuropeAnna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford

Life sciences cases at the UPC will surely rise, but is the court prepared?

Signs show that an uptick of life sciences cases at the Unified Patent Court is likely, but does the court have capacity? Anna Leathley, Richard Newell & Sarah Mitchell of Carpmaels & Ransford explore.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Europe

IP finance gap risks startup exodus, EUIPO warns

13 April 2026 New report finds that just 13% of IP-owning firms have sought financing through their assets, with billions in potential funding left untapped, as structural barriers persist.

Europe

Patent office fee increases: What applicants must know

13 April 2026 Europe’s latest patent fee increases are modest at the EPO but include a rare steep hike in the UK, forcing applicants to reassess filing routes, portfolio value, and long-term cost strategies, say James Bell and Yelena Morozova.

Europe

UK patent office adopts EPO standards for AI inventions

9 April 2026 In light of Emotional Perception AI, the UKIPO has rewritten the rules for “mixed inventions". Matt Jefferies and Eric McNeil of Marks & Clerk explore what this pivot means for applicants protecting their AI technology.

More features

IP finance gap risks startup exodus, EUIPO warns

Patent office fee increases: What applicants must know

UK patent office adopts EPO standards for AI inventions

European patent offices raise fees

UPC refuses early knockout in Illumina–Element dispute

IndiaMart v CDSCO: A test of intermediary liability

UPC appeals court upholds Abbott injunction in glucose monitoring patent dispute

WIPR debuts Global In-House Elite 2026

Life sciences cases at the UPC will surely rise, but is the court prepared?

More on this story

Editor's picks

Editor's picks

More features